S. Devaux
Paul Sabatier University
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by S. Devaux.
Journal of The European Academy of Dermatology and Venereology | 2012
E. Archier; S. Devaux; E. Castela; A. Gallini; F. Aubin; M. Le Maître; S. Aractingi; H. Bachelez; B. Cribier; Pascal Joly; D. Jullien; L. Misery; C. Paul; J.-P. Ortonne; M.-A. Richard
Background Oral 8‐methoxypsoralen–UV‐A (PUVA) and narrowband UV‐B (NB‐UVB or UVB TL‐01) are effective and widely used treatments for chronic plaque psoriasis. Although the role of PUVA therapy in skin carcinogenesis in humans with psoriasis has been clearly demonstrated, there is still controversy regarding the risk of skin cancer with NB‐UVB. Furthermore, there is no clear evidence about the maximum cumulative number of sessions not to be exceeded in a lifetime.
Journal of The European Academy of Dermatology and Venereology | 2012
S. Devaux; A. Castela; E. Archier; A. Gallini; Pascal Joly; L. Misery; S. Aractingi; F. Aubin; Hervé Bachelez; B. Cribier; D. Jullien; M. Le Maître; M.-A. Richard; J.-P. Ortonne; C. Paul
Background Treatment adherence has been recognized as an important issue in the management of chronic diseases such as psoriasis.
Journal of The European Academy of Dermatology and Venereology | 2012
E. Archier; S. Devaux; E. Castela; A. Gallini; F. Aubin; M. Le Maître; S. Aractingi; H. Bachelez; B. Cribier; Pascal Joly; D. Jullien; L. Misery; C. Paul; J.-P. Ortonne; M.-A. Richard
Background Oral 8‐methoxypsoralen‐UV‐A (PUVA) and Narrowband UV‐B (NB‐UVB or UVB TL‐01) are well established treatments for chronic plaque psoriasis but there is limited evidence regarding their respective efficacy.
Journal of The European Academy of Dermatology and Venereology | 2012
C. Paul; A. Gallini; E. Archier; E. Castela; S. Devaux; S. Aractingi; F. Aubin; H. Bachelez; B. Cribier; Pascal Joly; D. Jullien; M. Le Maître; L. Misery; M.-A. Richard; J.-P. Ortonne
Background Although topical treatments and phototherapy are available for more than 40 years, there is a paucity of evidence‐based recommendations regarding their use.
Journal of The European Academy of Dermatology and Venereology | 2012
E. Castela; E. Archier; S. Devaux; A. Gallini; S. Aractingi; B. Cribier; D. Jullien; F. Aubin; H. Bachelez; Pascal Joly; M. Le Maître; L. Misery; M.-A. Richard; C. Paul; J.-P. Ortonne
Background Topical steroids have been used for more than 50 years in mild‐to‐moderate plaque psoriasis and carry a theoretical risk of adverse events.
Journal of The European Academy of Dermatology and Venereology | 2012
S. Devaux; A. Castela; E. Archier; A. Gallini; Pascal Joly; L. Misery; S. Aractingi; F. Aubin; H. Bachelez; B. Cribier; D. Jullien; M. Le Maître; M.-A. Richard; J.-P. Ortonne; C. Paul
Objective The objective of this systematic review was to prepare for evidence‐based recommendations on the use of vitamin D analogues, and their combination with topical steroids in psoriasis.
Journal of The European Academy of Dermatology and Venereology | 2012
E. Castela; E. Archier; S. Devaux; A. Gallini; S. Aractingi; B. Cribier; D. Jullien; F. Aubin; H. Bachelez; Pascal Joly; M. Le Maître; L. Misery; M.-A. Richard; C. Paul; J.-P. Ortonne
Introduction Topical steroids are used for more than 50 years to treat mild‐to‐moderate plaque psoriasis. The purpose of this systematic review was to evaluate the efficacy but also the optimal modalities of administration of topical corticosteroids in psoriasis i.e. influence of steroid potency on clinical response, putative impact of topical formulation, occlusion procedure, rate of application to control the initial response and the potential interest of a maintenance treatment to prolong psoriasis clearance.
Journal of The European Academy of Dermatology and Venereology | 2012
E. Archier; S. Devaux; E. Castela; A. Gallini; F. Aubin; M. Le Maître; S. Aractingi; Hervé Bachelez; B. Cribier; Pascal Joly; D. Jullien; L. Misery; C. Paul; J.-P. Ortonne; M.-A. Richard
Ocular damage in patients with psoriasis treated by Psoralen UV-A therapy or Narrow band UVB therapy: a systematic literature review E. Archier, S. Devaux, E. Castela, A. Gallini, F. Aubin,** M. Le Maı̂tre, S. Aractingi, H. Bachelez, B. Cribier, P. Joly,*** D. Jullien, L. Misery, C. Paul, J.P. Ortonne, M.A. Richard Aix-Marseille Univ, UMR 911, INSERM CRO2 and Dermatology Department, Timone Hospital, Marseille, France Dermatology Department, Paul Sabatier University, Toulouse, France Dermatology Department, Nice University, L’Archet II Hospital, Nice, France UMR 1027 INSERM, Paul Sabatier University, Toulouse, France **Dermatology Department, Franche-Comté University, EA3181, IFR133, University Hospital, Besançon, France Dermatologist, Caen, France Dermatology Department, Tenon Hospital, APHP and Paris 6 University, Paris, France Dermatology Department, Saint-Louis Hospital, Paris, France Dermatology Department, University Hospital, Strasbourg, France ***Dermatology Department, Charles Nicolle Hospital, INSERM U 905, University of Rouen, France Dermatology Department, Edouard Herriot Hospital, Lyon, France Dermatology Department, University Hospital, Brest, France *Correspondence: E. Archier. E-mail: [email protected]
Archive | 2013
Helene Pol; S. Devaux; Francoise Fortenfant; C. Paul
Journal of The American Academy of Dermatology | 2013
Helene Pol; S. Devaux; E. Tournier; Francoise Fortenfant; C. Paul